Literature DB >> 32278359

The state of vaccine safety science: systematic reviews of the evidence.

Matthew Z Dudley1, Neal A Halsey2, Saad B Omer3, Walter A Orenstein4, Sean T O'Leary5, Rupali J Limaye6, Daniel A Salmon7.   

Abstract

This Review updates the scientific evidence assessing possible causal associations of adverse events following immunisation (AEFI) compiled in the 2012 report from the Institute of Medicine and the 2014 report from the Agency for Healthcare Research and Quality. For 12 of 46 AEFI examined, a causal relationship has been established with at least one vaccine currently routinely recommended to the general USA population: anaphylaxis, arthralgia or arthritis (mild, acute, and transient, not chronic), deltoid bursitis (when vaccine is administered improperly), disseminated varicella infection (in immune deficient individuals for whom the varicella vaccine is contraindicated), encephalitis, febrile seizures, Guillain-Barré syndrome, hepatitis (in immune deficient individuals for whom the varicella vaccine is contraindicated), herpes zoster, immune thrombocytopenic purpura, meningitis, and syncope. Other than mild acute and transient arthralgia or arthritis, which is very common in adult women after rubella vaccine, these adverse reactions are rare or very rare. Vaccines have an excellent safety profile overall and provide protection against infectious diseases to individuals and the general population.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32278359     DOI: 10.1016/S1473-3099(20)30130-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  18 in total

1.  Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database.

Authors:  Tosin Yinka Akintunde; Shaojun Chen; Taha Hussein Musa; Felix Oluseyi Amoo; Adekunle Adedeji; Elhakim Ibrahim; Angwi Enow Tassang; Idriss Hussein Musa; Hassan Hussein Musa
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

2.  Politicizing public health: the powder keg of rushing COVID-19 vaccines.

Authors:  Rupali J Limaye; Molly Sauer; Shaun A Truelove
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452

Review 3.  An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.

Authors:  Cielo García-Montero; Oscar Fraile-Martínez; Coral Bravo; Diego Torres-Carranza; Lara Sanchez-Trujillo; Ana M Gómez-Lahoz; Luis G Guijarro; Natalio García-Honduvilla; Angel Asúnsolo; Julia Bujan; Jorge Monserrat; Encarnación Serrano; Melchor Álvarez-Mon; Juan A De León-Luis; Miguel A Álvarez-Mon; Miguel A Ortega
Journal:  Vaccines (Basel)       Date:  2021-04-27

4.  The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.

Authors:  Steven B Black; Barbara Law; Robert T Chen; Cornelia L Dekker; Miriam Sturkenboom; Wan-Ting Huang; Marc Gurwith; Greg Poland
Journal:  Vaccine       Date:  2021-03-06       Impact factor: 3.641

5.  Making sense of unfamiliar COVID-19 vaccines: How national origin affects vaccination willingness.

Authors:  Eric A Jensen; Brady Wagoner; Axel Pfleger; Lisa Herbig; Meike Watzlawik
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

6.  COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria.

Authors:  Obi Peter Adigwe
Journal:  Vaccine X       Date:  2021-09-03

Review 7.  mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.

Authors:  Yingqi Jin; Chen Hou; Yonghao Li; Kang Zheng; Chuan Wang
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

8.  Aseptic Meningitis Following Second Dose of an mRNA Coronavirus Disease 2019 Vaccine in a Healthy Male: Case Report and Literature Review.

Authors:  Han Sol Kang; Ju Eun Kim; Jeong Rae Yoo; Hyunjoo Oh; Misun Kim; Young Ree Kim; Sang Taek Heo
Journal:  Infect Chemother       Date:  2022-01-27

9.  Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes.

Authors:  Stéphane Mathis; Antoine Soulages; Gwendal Le Masson; Jean-Michel Vallat
Journal:  J Neurol       Date:  2020-09-10       Impact factor: 4.849

10.  COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases.

Authors:  Larisa Pinte; Florentina Negoi; Georgeta Daniela Ionescu; Simona Caraiola; Daniel Vasile Balaban; Camelia Badea; Diana Mazilu; Bianca Dumitrescu; Bogdan Mateescu; Ruxandra Ionescu; Magda Ileana Parvu; Cristian Baicus
Journal:  J Pers Med       Date:  2021-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.